
|Videos|January 27, 2021
Visus CEO updates on lead product candidate, 2021 pipeline
Author(s)OT Staff Reports
Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
2
Pterygium width may help predict corneal optical disturbance
3
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
4
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
5























